eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.white house to ban federal funds for clinics that discuss abortion with patients : the two-way
.
.
.
viewpoint: china has the upper hand in cancer cell therapy
.
.
county grand jury report finds shortcomings in hepatitis response
.
october 2009 (42)
.
.
.
helen, who has five siblings and in her home state in high school fronted the state band as the lead baton twirler, juggled a lot around the house.
.